ICU Total Liab vs Net Receivables Analysis

ICUI Stock

USD 103.24 0.75 0.72%

ICU Medical financial indicator trend analysis is infinitely more than just investigating ICU Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ICU Medical is a good investment. Please check the relationship between ICU Medical Total Liab and its Net Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

Total Liab vs Net Receivables

Total Liab vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ICU Medical Total Liab account and Net Receivables. At this time, the significance of the direction appears to have strong relationship.

The correlation between ICU Medical's Total Liab and Net Receivables is 0.6. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Net Receivables in the same time period over historical financial statements of ICU Medical, assuming nothing else is changed. The correlation between historical values of ICU Medical's Total Liab and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of ICU Medical are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Total Liab i.e., ICU Medical's Total Liab and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.6

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Net Receivables

Most indicators from ICU Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ICU Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.As of now, ICU Medical's Enterprise Value Multiple is increasing as compared to previous years.

	2021	2022	2023	2024 (projected)
Gross Profit	491.5M	697.8M	709.8M	745.3M
Total Revenue	1.3B	2.3B	2.3B	2.4B

Gross Profit Total Revenue

ICU Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Total	Other Current Assets	Intangible Assets	Common Stock Total Equity	Short Term Investments	Common Stock	Other Assets
Total Assets		0.98	0.98	0.94	0.92	0.87	0.78	0.92	0.03	0.99	-0.28	-0.06	0.73	0.67	0.99	0.98	0.97	0.94	0.9	0.94	0.86	0.98	0.66	-0.36	0.73	0.81
Other Current Liab	0.98		1.0	0.96	0.96	0.8	0.81	0.94	0.06	0.95	-0.41	-0.03	0.83	0.73	1.0	0.99	0.91	0.95	0.93	0.87	0.76	0.94	0.72	-0.41	0.78	0.86
Total Current Liabilities	0.98	1.0		0.96	0.96	0.82	0.79	0.96	0.03	0.96	-0.4	-0.06	0.82	0.71	1.0	0.99	0.93	0.94	0.92	0.89	0.78	0.95	0.7	-0.41	0.77	0.84
Total Stockholder Equity	0.94	0.96	0.96		0.99	0.67	0.93	0.92	0.29	0.89	-0.37	0.2	0.82	0.82	0.96	0.98	0.83	0.92	0.99	0.78	0.66	0.87	0.82	-0.36	0.86	0.93
Property Plant And Equipment Net	0.92	0.96	0.96	0.99		0.65	0.9	0.95	0.21	0.87	-0.46	0.13	0.86	0.81	0.96	0.97	0.8	0.9	0.96	0.75	0.6	0.85	0.81	-0.45	0.85	0.94
Net Debt	0.87	0.8	0.82	0.67	0.65		0.4	0.72	-0.4	0.93	-0.15	-0.47	0.43	0.28	0.83	0.78	0.97	0.81	0.58	0.98	0.96	0.94	0.28	-0.32	0.37	0.48
Retained Earnings	0.78	0.81	0.79	0.93	0.9	0.4		0.79	0.57	0.7	-0.19	0.52	0.75	0.9	0.8	0.84	0.61	0.75	0.95	0.55	0.45	0.67	0.89	-0.23	0.9	0.9
Accounts Payable	0.92	0.94	0.96	0.92	0.95	0.72	0.79		0.07	0.89	-0.4	-0.01	0.89	0.77	0.95	0.95	0.85	0.83	0.91	0.8	0.66	0.88	0.73	-0.41	0.81	0.81
Cash	0.03	0.06	0.03	0.29	0.21	-0.4	0.57	0.07		-0.09	0.07	0.98	0.2	0.59	0.03	0.12	-0.18	0.01	0.4	-0.23	-0.25	-0.12	0.57	0.28	0.52	0.36
Non Current Assets Total	0.99	0.95	0.96	0.89	0.87	0.93	0.7	0.89	-0.09		-0.26	-0.17	0.66	0.58	0.97	0.95	0.99	0.93	0.83	0.98	0.91	1.0	0.57	-0.36	0.65	0.75
Non Currrent Assets Other	-0.28	-0.41	-0.4	-0.37	-0.46	-0.15	-0.19	-0.4	0.07	-0.26		0.2	-0.45	-0.19	-0.4	-0.42	-0.2	-0.4	-0.32	-0.15	0.07	-0.24	-0.22	0.44	-0.19	-0.51
Cash And Short Term Investments	-0.06	-0.03	-0.06	0.2	0.13	-0.47	0.52	-0.01	0.98	-0.17	0.2		0.12	0.52	-0.06	0.02	-0.26	-0.06	0.32	-0.3	-0.29	-0.21	0.51	0.27	0.45	0.27
Net Receivables	0.73	0.83	0.82	0.82	0.86	0.43	0.75	0.89	0.2	0.66	-0.45	0.12		0.83	0.8	0.81	0.6	0.68	0.85	0.53	0.37	0.64	0.79	-0.38	0.83	0.74
Common Stock Shares Outstanding	0.67	0.73	0.71	0.82	0.81	0.28	0.9	0.77	0.59	0.58	-0.19	0.52	0.83		0.7	0.74	0.5	0.6	0.88	0.43	0.32	0.55	0.99	-0.22	0.99	0.79
Inventory	0.99	1.0	1.0	0.96	0.96	0.83	0.8	0.95	0.03	0.97	-0.4	-0.06	0.8	0.7		0.99	0.93	0.95	0.92	0.9	0.79	0.96	0.7	-0.41	0.76	0.85
Other Stockholder Equity	0.98	0.99	0.99	0.98	0.97	0.78	0.84	0.95	0.12	0.95	-0.42	0.02	0.81	0.74	0.99		0.91	0.95	0.95	0.86	0.75	0.93	0.73	-0.4	0.79	0.89
Total Liab	0.97	0.91	0.93	0.83	0.8	0.97	0.61	0.85	-0.18	0.99	-0.2	-0.26	0.6	0.5	0.93	0.91		0.89	0.76	1.0	0.95	0.99	0.48	-0.32	0.57	0.65
Property Plant And Equipment Gross	0.94	0.95	0.94	0.92	0.9	0.81	0.75	0.83	0.01	0.93	-0.4	-0.06	0.68	0.6	0.95	0.95	0.89		0.87	0.86	0.78	0.9	0.64	-0.39	0.66	0.83
Total Current Assets	0.9	0.93	0.92	0.99	0.96	0.58	0.95	0.91	0.4	0.83	-0.32	0.32	0.85	0.88	0.92	0.95	0.76	0.87		0.71	0.6	0.81	0.86	-0.3	0.9	0.91
Non Current Liabilities Total	0.94	0.87	0.89	0.78	0.75	0.98	0.55	0.8	-0.23	0.98	-0.15	-0.3	0.53	0.43	0.9	0.86	1.0	0.86	0.71		0.97	0.98	0.42	-0.29	0.51	0.59
Other Current Assets	0.86	0.76	0.78	0.66	0.6	0.96	0.45	0.66	-0.25	0.91	0.07	-0.29	0.37	0.32	0.79	0.75	0.95	0.78	0.6	0.97		0.92	0.31	-0.18	0.4	0.44
Intangible Assets	0.98	0.94	0.95	0.87	0.85	0.94	0.67	0.88	-0.12	1.0	-0.24	-0.21	0.64	0.55	0.96	0.93	0.99	0.9	0.81	0.98	0.92		0.54	-0.35	0.63	0.72
Common Stock Total Equity	0.66	0.72	0.7	0.82	0.81	0.28	0.89	0.73	0.57	0.57	-0.22	0.51	0.79	0.99	0.7	0.73	0.48	0.64	0.86	0.42	0.31	0.54		-0.26	0.98	0.79
Short Term Investments	-0.36	-0.41	-0.41	-0.36	-0.45	-0.32	-0.23	-0.41	0.28	-0.36	0.44	0.27	-0.38	-0.22	-0.41	-0.4	-0.32	-0.39	-0.3	-0.29	-0.18	-0.35	-0.26		-0.28	-0.4
Common Stock	0.73	0.78	0.77	0.86	0.85	0.37	0.9	0.81	0.52	0.65	-0.19	0.45	0.83	0.99	0.76	0.79	0.57	0.66	0.9	0.51	0.4	0.63	0.98	-0.28		0.81
Other Assets	0.81	0.86	0.84	0.93	0.94	0.48	0.9	0.81	0.36	0.75	-0.51	0.27	0.74	0.79	0.85	0.89	0.65	0.83	0.91	0.59	0.44	0.72	0.79	-0.4	0.81

Click cells to compare fundamentals

ICU Medical Account Relationship Matchups

ICU Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.7B	1.8B	1.9B	4.5B	4.4B	4.6B
Other Current Liab	105.8M	109.3M	98.0M	218.1M	228.1M	239.6M
Total Current Liabilities	248.5M	195.5M	200.8M	494.6M	481.8M	505.9M
Total Stockholder Equity	1.4B	1.5B	1.6B	2.1B	2.1B	2.2B
Property Plant And Equipment Net	490.6M	513.2M	508.2M	711.0M	682.8M	717.0M
Net Debt	(232.4M)	(344.0M)	(507.8M)	1.4B	1.5B	1.5B
Retained Earnings	721.8M	808.7M	911.8M	837.5M	807.8M	848.2M
Accounts Payable	128.6M	71.9M	81.1M	215.9M	150.0M	157.5M
Cash	268.7M	396.1M	552.8M	208.8M	254.2M	137.4M
Non Current Assets Total	810.2M	842.9M	850.9M	3.3B	3.2B	3.3B
Non Currrent Assets Other	49.0M	55.5M	63.7M	105.5M	56.4M	59.2M
Cash And Short Term Investments	292.6M	410.8M	567.2M	213.0M	254.7M	178.0M
Net Receivables	202.2M	124.1M	105.9M	221.7M	164.3M	172.5M
Common Stock Shares Outstanding	21.5M	21.6M	21.8M	23.9M	24.1M	17.2M
Liabilities And Stockholders Equity	1.7B	1.8B	1.9B	4.5B	4.4B	4.6B
Inventory	337.6M	314.9M	290.2M	696.0M	709.4M	744.8M
Other Stockholder Equity	668.8M	693.0M	721.4M	1.3B	1.4B	1.4B
Total Liab	315.1M	261.4M	264.7M	2.4B	2.3B	2.4B
Property Plant And Equipment Gross	490.6M	513.2M	468.4M	711.0M	1.3B	1.4B
Total Current Assets	882.2M	920.8M	1.0B	1.2B	1.2B	1.3B
Accumulated Other Comprehensive Income	(15.4M)	(1.5M)	(19.3M)	(81.0M)	(53.1M)	(50.4M)
Non Current Liabilities Total	66.7M	65.9M	63.9M	1.9B	1.8B	1.9B
Other Current Assets	4.4M	1.8M	2.2M	88.9M	91.2M	95.8M
Intangible Assets	211.4M	197.2M	188.3M	982.8M	870.6M	914.1M
Common Stock Total Equity	2.0M	2.1M	2.1M	2.1M	2.4M	1.7M
Short Term Investments	24.0M	14.7M	14.4M	4.2M	501K	476.0K
Common Stock	2.1M	2.1M	2.1M	2.4M	2.4M	1.8M
Other Assets	77.0M	146.1M	106.3M	104.4M	120.1M	126.1M
Treasury Stock	(95K)	(157K)	(39K)	(27K)	(31.1K)	(32.6K)
Property Plant Equipment	456.1M	466.6M	468.4M	713.6M	820.6M	861.6M
Other Liab	37.8M	18.1M	22.1M	244.7M	281.4M	295.5M
Net Tangible Assets	1.2B	1.3B	1.6B	(342.1M)	(393.4M)	(373.7M)
Current Deferred Revenue	6.7M	5.6M	12.6M	30.8M	31.6M	33.2M
Good Will	31.2M	33.0M	43.4M	1.4B	1.5B	1.5B
Retained Earnings Total Equity	620.7M	721.8M	808.7M	911.8M	1.0B	553.4M
Capital Surpluse	657.9M	668.9M	693.1M	721.4M	829.6M	871.1M
Deferred Long Term Liab	2.1M	1.7M	1.5M	5.2M	4.6M	2.7M
Long Term Investments	0.0	13.0M	4.6M	3.7M	3.1M	4.2M
Non Current Liabilities Other	47.3M	64.3M	62.4M	54.4M	33.9M	27.4M

Currently Active Assets on Macroaxis

VWITX	Vanguard Intermediate Term Tax Exempt
VGSTX	Vanguard Star Fund
VFIAX	Vanguard 500 Index
VTCLX	Vanguard Tax Managed Capital
VTSAX	Vanguard Total Stock

When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:

How To Invest In ICU

Details

Is ICU Stock a good investment?

Details

What is ICU Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for ICU Stock analysis

When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.

	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories

Is ICU Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.24)

Earnings Share

(2.45)

Revenue Per Share

93.49

Quarterly Revenue Growth

(0)

Return On Assets

0.0048

The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ICU Total Liab vs Net Receivables Analysis

Total Liab vs Net Receivables

Total Liab vs Net Receivables Correlation Analysis

Correlation Coefficient

Total Liab

Net Receivables

ICU Medical fundamental ratios Correlations

ICU Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ICU Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for ICU Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Other Current Liab
Inventory	+ 1.0	Other Current Liab
Inventory	+ 1.0	Total Current Liabilities
Intangible Assets	+ 1.0	Non Current Assets Total
Non Current Liabilities Total	+ 1.0	Total Liab
Non Current Assets Total	+ 0.99	Total Assets

Other Assets	- 0.51	Non Currrent Assets Other
Cash And Short Term Investments	- 0.47	Net Debt
Non Currrent Assets Other	- 0.46	Property Plant And Equipment Net
Net Receivables	- 0.45	Non Currrent Assets Other
Short Term Investments	- 0.45	Property Plant And Equipment Net
Other Stockholder Equity	- 0.42	Non Currrent Assets Other